The 6-min walk distance in pulmonary arterial hypertension: "Je t'aime, moi non plus"

Chest

Volumn 137, Issue 6, 2010, Pages 1258-1260

  Naeije, Robert ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DISEASE SEVERITY; EDITORIAL; EXERCISE; EXERCISE TEST; HEART OUTPUT MEASUREMENT; HUMAN; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WALKING;

EID: 77953306364     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0351     Document Type: Editorial

References (19)

1. McLaughlin VV, Archer SL, Badesch DB, et al; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250-2294.
2. . Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009;30(4):394-403.
3. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S55-S66.
4. Fleg JL, Piña IL, Balady GJ, et al. Assessment of functional capacity in clinical and research applications: an advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American Heart Association . Circulation. 2000;102(13):1591-1597.
5. Deboeck G, Niset G, Vachiery JL, Moraine JJ, Naeije R. Physiological response to the six-minute walk test in pulmonary arterial hypertension. Eur Respir J. 2005;26(4):667-672.
6. Roberts K, Preston I, Hill NS. Pulmonary hypertension trials: current end points are flawed, but what are the alternatives? Chest. 2006;130(4):934-936.
7. . Rich S . The current treatment of pulmonary arterial hypertension: time to redefine success. Chest. 2006;130(4):1198-1202.
8. Peacock AJ, Naeije R, Galiè N, Rubin L. End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? Eur Respir J. 2009;34(1):231-242.
9. Degano B, Sitbon O, Savale L, et al. Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6-min at diagnosis. Chest. 2010;137(6):1297-1303.
10. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104(4):429-435. (Pubitemid 32678273)
11. Meyer FJ, Lossnitzer D, Kristen AV, et al. Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J. 2005;25(1):125-130.
12. Bauer R, Dehnert C, Schoene P, et al. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med. 2007;101(11):2366-2369.
13. Naeije R. Breathing more with weaker respiratory muscles in pulmonary arterial hypertension . Eur Respir J. 2005;25(1):6-8.
14. Tolle J, Waxman A, Systrom D. Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension . Med Sci Sports Exerc. 2008;40(1):3-8.
15. Wong YY, van der Laarse WJ, Vonk-Noordegraaf A. Reduced systemic oxygen extraction does not prove muscle dysfunction in PAH. Med Sci Sports Exerc. 2008;40(8):1554-1555.
16. Cooper KH. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA. 1968;203(3):201-204.
17. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161(2 pt 1):487-492. (Pubitemid 30129457)
18. Frost AE, Langleben D, Oudiz R, et al. The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascul Pharmacol. 2005;43(1):36-39.
19. Shah SJ, Thenappan T, Rich S, Sur J, Archer SL, Gomberg- Maitland M. Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension. Circ Heart Fail. 2009;2(4):278-286.